StockNews.AI
HAE
StockNews.AI
8 hrs

Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2026 Results: November 6, 2025

1. Haemonetics plans to release Q2 FY2026 financial results on November 6, 2025. 2. Conference call scheduled for detailed discussion about results at 8:00 am ET. 3. The company's innovative healthcare solutions are highlighted in the announcement. 4. The call will be accessible via teleconference and will feature a live webcast. 5. Results will reflect the effectiveness of Haemonetics' healthcare technology innovations.

Earnings
0%Current Return
VS
0%S&P 500
$50.1510/09 04:14 PM EDTEvent Start
$50.1510/09 11:59 PM EDTLatest Updated
5m saved
Insight
Article

FAQ

Why Bullish?

Upcoming earnings call suggests potential positive performance reflecting market sentiment historically seen around earnings announcements.

How important is it?

Earnings announcements traditionally attract investor attention and can significantly impact stock prices.

Why Short Term?

The imminent nature of the earnings report could lead to immediate price fluctuations.

Related Companies

ABTGHDXPTCT
, /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish second quarter fiscal year 2026 financial results at 6:00 am ET on Thursday, November 6, 2025. The Company will hold a conference call with investors and analysts to discuss results and answer questions at 8:00 am ET on November 6, 2025. The call can be accessed via teleconference at: Q2 2026 Haemonetics Corporation Earnings Conference Call. Once registration is completed, participants will receive a dial-in number along with a personalized PIN to access the call. While not required, it is recommended that participants join 10 minutes prior to the event start. A live webcast of the call can be accessed on Haemonetics' investor relations website. Webcast Link: https://edge.media-server.com/mmc/p/6q36mw7d A replay of the conference call and webcast will be available for one year beginning on November 6, 2025 at 11:00 am ET using the conference call webcast link provided in this press release. ABOUT HAEMONETICS Haemonetics is a global medical technology company dedicated to improving the quality, effectiveness and efficiency of health care. Our innovative solutions addressing critical medical needs include a suite of hospital technologies designed to advance standards of care and help enhance outcomes for patients; end-to-end plasma collection technologies to optimize operations for plasma centers; and products to enable blood centers to collect in-demand blood components. To learn more about Haemonetics, visit www.haemonetics.com. Investor Contacts: Olga Guyette, Vice President-Investor Relations & Treasury           David Trenk, Manager-Investor Relations (781) 356-9763 (203) 733-4987 [email protected] [email protected] Media Contact: Josh Gitelson, Sr. Director-Global Communications (781) 356-9776 [email protected] SOURCE Haemonetics Corporation WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? 440k+ Newsrooms & Influencers 9k+ Digital Media Outlets 270k+ Journalists Opted In

Related News